Number of the records: 1
antivirotiká
SYS d000998 LBL 00000cz--a2200000n--4500 005 20250606212845.4 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D27.505.954.122.388 066 $a 01 $c 03 150 $a antivirotiká $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Antiviral $2 eng 450 $w v $a Antiviral Agent $2 eng 450 $w v $a Antiviral Drug $2 eng 450 $w v $a Antivirals $2 eng 450 $w v $a látky antivírusové $2 slo 450 $w v $a virostatiká $2 slo 450 $w v $a antivirotikum $2 slo 550 $7 sllk_us_auth*d018894 $Y Reverse Transcriptase Inhibitors $w p $a inhibítory reverznej transkriptázy 550 $7 sllk_us_auth*d038301 $Y Virus Inactivation $w p $a inaktivácia vírusu 550 $7 sllk_us_auth*d007369 $Y Interferon Inducers $w b $a induktory interferónu 550 $7 sllk_us_auth*d014777 $Y Virus Diseases $w b $a choroby vírusové 550 $7 sllk_us_auth*d014780 $Y Viruses $w b $a vírusy 550 $7 sllk_us_auth*d038301 $Y Virus Inactivation $w b $a inaktivácia vírusu 680 9-
$i Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. $2 eng 680 $a for resistance to antiviral agents, DRUG RESISTANCE, VIRAL and DRUG RESISTANCE, MULTIPLE, VIRAL are available $2 eng 750 -2
$a Antiviral Agents $2 eng 980 $x M
Number of the records: 1